全文获取类型
收费全文 | 178篇 |
免费 | 19篇 |
国内免费 | 4篇 |
专业分类
201篇 |
出版年
2022年 | 3篇 |
2021年 | 4篇 |
2019年 | 1篇 |
2018年 | 3篇 |
2017年 | 4篇 |
2016年 | 6篇 |
2015年 | 5篇 |
2014年 | 13篇 |
2013年 | 17篇 |
2012年 | 13篇 |
2011年 | 21篇 |
2010年 | 14篇 |
2009年 | 6篇 |
2008年 | 5篇 |
2007年 | 11篇 |
2006年 | 7篇 |
2005年 | 10篇 |
2004年 | 11篇 |
2003年 | 4篇 |
2002年 | 12篇 |
2001年 | 7篇 |
2000年 | 1篇 |
1999年 | 1篇 |
1998年 | 1篇 |
1997年 | 2篇 |
1995年 | 2篇 |
1994年 | 3篇 |
1993年 | 3篇 |
1992年 | 1篇 |
1988年 | 2篇 |
1986年 | 1篇 |
1984年 | 4篇 |
1976年 | 1篇 |
1945年 | 1篇 |
1923年 | 1篇 |
排序方式: 共有201条查询结果,搜索用时 11 毫秒
111.
International clinical recommendations on scar management 总被引:44,自引:0,他引:44
Mustoe TA Cooter RD Gold MH Hobbs FD Ramelet AA Shakespeare PG Stella M Téot L Wood FM Ziegler UE;International Advisory Panel on Scar Management 《Plastic and reconstructive surgery》2002,110(2):560-571
Many techniques for management of hypertrophic scars and keloids have been proven through extensive use, but few have been supported by prospective studies with adequate control groups. Several new therapies showed good results in small-scale trials, but these have not been repeated in larger trials with long-term follow-up. This article reports a qualitative overview of the available clinical literature by an international panel of experts using standard methods of appraisal. The article provides evidence-based recommendations on prevention and treatment of abnormal scarring and, where studies are insufficient, consensus on best practice. The recommendations focus on the management of hypertrophic scars and keloids, and are internationally applicable in a range of clinical situations. These recommendations support a move to a more evidence-based approach in scar management. This approach highlights a primary role for silicone gel sheeting and intralesional corticosteroids in the management of a wide variety of abnormal scars. The authors concluded that these are the only treatments for which sufficient evidence exists to make evidence-based recommendations. A number of other therapies that are in common use have achieved acceptance by the authors as standard practice. However, it is highly desirable that many standard practices and new emerging therapies undergo large-scale studies with long-term follow-up before being recommended conclusively as alternative therapies for scar management. 相似文献
112.
113.
114.
115.
116.
CEP290 mutations are frequently identified in the oculo-renal form of Joubert syndrome-related disorders
下载免费PDF全文
![点击此处可从《American journal of human genetics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Brancati F Barrano G Silhavy JL Marsh SE Travaglini L Bielas SL Amorini M Zablocka D Kayserili H Al-Gazali L Bertini E Boltshauser E D'Hooghe M Fazzi E Fenerci EY Hennekam RC Kiss A Lees MM Marco E Phadke SR Rigoli L Romano S Salpietro CD Sherr EH Signorini S Stromme P Stuart B Sztriha L Viskochil DH Yuksel A Dallapiccola B;International JSRD Study Group Valente EM Gleeson JG 《American journal of human genetics》2007,81(1):104-113
Joubert syndrome–related disorders (JSRDs) are a group of clinically and genetically heterogeneous conditions that share a midbrain-hindbrain malformation, the molar tooth sign (MTS) visible on brain imaging, with variable neurological, ocular, and renal manifestations. Mutations in the CEP290 gene were recently identified in families with the MTS-related neurological features, many of which showed oculo-renal involvement typical of Senior-Löken syndrome (JSRD-SLS phenotype). Here, we performed comprehensive CEP290-mutation analysis on two nonoverlapping cohorts of JSRD-affected patients with a proven MTS. We identified mutations in 19 of 44 patients with JSRD-SLS. The second cohort consisted of 84 patients representing the spectrum of other JSRD subtypes, with mutations identified in only two patients. The data suggest that CEP290 mutations are frequently encountered and are largely specific to the JSRD-SLS subtype. One patient with mutation displayed complete situs inversus, confirming the clinical and genetic overlap between JSRDs and other ciliopathies. 相似文献
117.
Xiao-Qing Wang Ze-Hui Jiang Research Institute of Wood Industry Chinese Academy of Forestry Beijing ChinaZeng-Yuan Li Guang Deng Research Institute of Forest Resource Information Techniques Chinese Academy of Forestry Beijing ChinaXing-E Liu International Centre for Bamboo Rattan Beijing China 《Acta Botanica Sinica》2007,(9)
There has been a great deal of interest in studying the crown of trees using remote sensing data.In this study,crownwidth was extracted from high-resolution QuickBird images for open Populus xiaohei plantations.Regression modelsfor predicting the individual stem volumes of Populus xiaohei were established using extracted crown width,as well asestimated tree parameters(i.e.diameter at breast height[DBH]and tree height)as predictors.Our results indicated thatcrown width could be accurately extracted from QuickBird images using a multi-scale segmentation approach with a meanrelative error of 5.74%,especially for wide-spacing stands.Using either extracted crown width alone or with estimatedDBH and tree height can successfully estimate individual stem volume of Populus xiaohei with the R~2 value ranging from0.87 to 0.92 depending on different model forms.In particular,the two second-order polynomial models(model2 andmodel 6),based on QuickBird image-derived crown widths and estimated DBH and tree heights,respectively,were the bestat describing the relationship between stem volume and tree characteristics. 相似文献
118.
119.
Stephen L. Walker Marivic Balagon Joydeepa Darlong Shimelis N. Doni Deanna A. Hagge Vikas Halwai Annamma John Saba M. Lambert Armi Maghanoy Jose A. C. Nery Kapil D. Neupane Peter G. Nicholls Vivek V. Pai Pawan Parajuli Anna M. Sales Euzenir Sarno Mahesh Shah Digafe Tsegaye Diana N. J. Lockwood Erythema Nodosum Leprosum International STudy Group 《PLoS neglected tropical diseases》2015,9(9)
Erythema nodosum leprosum (ENL) is a severe multisystem immune mediated complication of borderline lepromatous leprosy and lepromatous leprosy. ENL is associated with skin lesions, neuritis, arthritis, dactylitis, eye inflammation, osteitis, orchitis, lymphadenitis and nephritis. The treatment of ENL requires immunosuppression, which is often required for prolonged periods of time and may lead to serious adverse effects. ENL and its treatment is associated with increased mortality and economic hardship. Improved, evidence-based treatments for ENL are needed; however, defining the severity of ENL and outcome measures for treatment studies is difficult because of the multiple organ systems involved. A cross-sectional study was performed, by the members of the Erythema Nodosum Leprosum International STudy (ENLIST) Group, of patients with ENL attending seven leprosy referral centres in Brazil, Ethiopia, India, Nepal, the Philippines and the United Kingdom. We systematically documented the clinical features and type of ENL, its severity and the drugs used to treat it. Patients with chronic ENL were more likely to be assessed as having severe ENL. Pain, the most frequent symptom, assessed using a semi-quantitative scale was significantly worse in individuals with “severe” ENL. Our findings will determine the items to be included in a severity scale of ENL which we are developing and validating. The study also provides data on the clinical features of ENL, which can be incorporated into a definition of ENL and used for outcome measures in treatment studies. 相似文献
120.
James Yarmolinsky Virginia Díez-Obrero Tom G. Richardson Marie Pigeyre Jennifer Sjaarda Guillaume Par Venexia M. Walker Emma E. Vincent Vanessa Y. Tan Mireia Obn-Santacana Demetrius Albanes Jochen Hampe Andrea Gsur Heather Hampel Rish K. Pai Mark Jenkins Steven Gallinger Graham Casey Wei Zheng Christopher I. Amos the International Lung Cancer Consortium the PRACTICAL consortium the MEGASTROKE consortium George Davey Smith Richard M. Martin Victor Moreno 《PLoS medicine》2022,19(2)
BackgroundEpidemiological studies have reported conflicting findings on the potential adverse effects of long-term antihypertensive medication use on cancer risk. Naturally occurring variation in genes encoding antihypertensive drug targets can be used as proxies for these targets to examine the effect of their long-term therapeutic inhibition on disease outcomes.Methods and findingsWe performed a mendelian randomization analysis to examine the association between genetically proxied inhibition of 3 antihypertensive drug targets and risk of 4 common cancers (breast, colorectal, lung, and prostate). Single-nucleotide polymorphisms (SNPs) in ACE, ADRB1, and SLC12A3 associated (P < 5.0 × 10−8) with systolic blood pressure (SBP) in genome-wide association studies (GWAS) were used to proxy inhibition of angiotensin-converting enzyme (ACE), β-1 adrenergic receptor (ADRB1), and sodium-chloride symporter (NCC), respectively. Summary genetic association estimates for these SNPs were obtained from GWAS consortia for the following cancers: breast (122,977 cases, 105,974 controls), colorectal (58,221 cases, 67,694 controls), lung (29,266 cases, 56,450 controls), and prostate (79,148 cases, 61,106 controls). Replication analyses were performed in the FinnGen consortium (1,573 colorectal cancer cases, 120,006 controls). Cancer GWAS and FinnGen consortia data were restricted to individuals of European ancestry. Inverse-variance weighted random-effects models were used to examine associations between genetically proxied inhibition of these drug targets and risk of cancer. Multivariable mendelian randomization and colocalization analyses were employed to examine robustness of findings to violations of mendelian randomization assumptions. Genetically proxied ACE inhibition equivalent to a 1-mm Hg reduction in SBP was associated with increased odds of colorectal cancer (odds ratio (OR) 1.13, 95% CI 1.06 to 1.22; P = 3.6 × 10−4). This finding was replicated in the FinnGen consortium (OR 1.40, 95% CI 1.02 to 1.92; P = 0.035). There was little evidence of association of genetically proxied ACE inhibition with risk of breast cancer (OR 0.98, 95% CI 0.94 to 1.02, P = 0.35), lung cancer (OR 1.01, 95% CI 0.92 to 1.10; P = 0.93), or prostate cancer (OR 1.06, 95% CI 0.99 to 1.13; P = 0.08). Genetically proxied inhibition of ADRB1 and NCC were not associated with risk of these cancers. The primary limitations of this analysis include the modest statistical power for analyses of drug targets in relation to some less common histological subtypes of cancers examined and the restriction of the majority of analyses to participants of European ancestry.ConclusionsIn this study, we observed that genetically proxied long-term ACE inhibition was associated with an increased risk of colorectal cancer, warranting comprehensive evaluation of the safety profiles of ACE inhibitors in clinical trials with adequate follow-up. There was little evidence to support associations across other drug target–cancer risk analyses, consistent with findings from short-term randomized controlled trials for these medications.In a Mendelian randomization analysis, James Yarmolinsky and colleagues investigate associations between genetically-proxied inhibition of antihypertensive drug targets and breast, colorectal, lung, and prostate cancer risk. 相似文献